Description générale
Daunorubicin is an anthracycline antineoplastic agent that inhibits DNA and RNA synthesis. It is used in treatment protocols for acute lymphoblastic leukaemia, acute myelogenous leukaemia and acute promyelocytic leukaemia.
INN
Daunorubicin
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté pour la première fois en 1999
(TRS
895)
pour
Lymphoid leukaemia, not elsewhere classified
Ajouté en 1999
(TRS
895)
pour
Acute myeloid leukaemia with recurrent genetic abnormalities
Ajouté en 1999
(TRS
895)
pour
Myeloid leukaemia
Wikipédia
DrugBank
Recommandations
Section
Cytotoxic medicines
- Parenteral > General injections > IV: 50 mg in vial (as hydrochloride) powder for injection; 20 mg in vial (as hydrochloride) powder for injection; 2 mg per mL in vial (as hydrochloride); 5 mg per mL in vial (as hydrochloride)